Publication:
Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera.

Loading...
Thumbnail Image

Date

2022-08-30

Authors

Triguero, Ana
Pedraza, Alexandra
Pérez-Encinas, Manuel
Mata-Vázquez, María Isabel
Vélez, Patricia
Fox, Laura
Gómez-Calafat, Montse
García-Delgado, Regina
Gasior, Mercedes
Ferrer-Marín, Francisca

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Hematological control, incidence of complications, and need for cytoreduction were studied in 453 patients with low-risk polycythemia vera (PV) treated with phlebotomies alone. Median hematocrit value decreased from 54% at diagnosis to 45% at 12 months, and adequate hematocrit control over time ( 60 years, and microvascular symptoms constituted the main indications for starting cytoreduction. Median duration without initiating cytoreduction was significantly longer in patients younger than 50 years (

Description

MeSH Terms

Humans
Leukemia, Myeloid, Acute
Middle Aged
Phlebotomy
Polycythemia Vera
Primary Myelofibrosis
Registries
Thrombosis

DeCS Terms

CIE Terms

Keywords

Low-risk, Myelofibrosis, Phlebotomies, Polycythemia vera, Thrombosis

Citation